company background image
A008930 logo

Hanmi Science KOSE:A008930 Stock Report

Last Price

₩32.90k

Market Cap

₩2.2t

7D

2.2%

1Y

-4.1%

Updated

13 Oct, 2024

Data

Company Financials

Hanmi Science Co., Ltd.

KOSE:A008930 Stock Report

Market Cap: ₩2.2t

A008930 Stock Overview

Through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally.

A008930 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health3/6
Dividends2/6

Rewards

Risk Analysis

No risks detected for A008930 from our risk checks.

Hanmi Science Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hanmi Science
Historical stock prices
Current Share Price₩32,900.00
52 Week High₩56,200.00
52 Week Low₩25,750.00
Beta1.03
11 Month Change-0.45%
3 Month Change-1.05%
1 Year Change-4.08%
33 Year Change-42.95%
5 Year Change-11.19%
Change since IPO7,021.96%

Recent News & Updates

Returns On Capital Are Showing Encouraging Signs At Hanmi Science (KRX:008930)

Aug 30
Returns On Capital Are Showing Encouraging Signs At Hanmi Science (KRX:008930)

Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly

Aug 13
Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly

Recent updates

Returns On Capital Are Showing Encouraging Signs At Hanmi Science (KRX:008930)

Aug 30
Returns On Capital Are Showing Encouraging Signs At Hanmi Science (KRX:008930)

Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly

Aug 13
Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly

Hanmi Science Co., Ltd. (KRX:008930) Not Flying Under The Radar

Jul 22
Hanmi Science Co., Ltd. (KRX:008930) Not Flying Under The Radar

Is Hanmi Science (KRX:008930) Using Too Much Debt?

Apr 29
Is Hanmi Science (KRX:008930) Using Too Much Debt?

Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Jan 31
Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt

Jan 05
We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt

Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%

Dec 06
Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%

Shareholder Returns

A008930KR HealthcareKR Market
7D2.2%-3.1%0.9%
1Y-4.1%-5.2%3.8%

Return vs Industry: A008930 exceeded the KR Healthcare industry which returned -5.2% over the past year.

Return vs Market: A008930 underperformed the KR Market which returned 3.8% over the past year.

Price Volatility

Is A008930's price volatile compared to industry and market?
A008930 volatility
A008930 Average Weekly Movement6.3%
Healthcare Industry Average Movement6.9%
Market Average Movement6.8%
10% most volatile stocks in KR Market12.2%
10% least volatile stocks in KR Market3.6%

Stable Share Price: A008930 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A008930's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1973403Jong-Hoon Limwww.hanmiscience.co.kr

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment.

Hanmi Science Co., Ltd. Fundamentals Summary

How do Hanmi Science's earnings and revenue compare to its market cap?
A008930 fundamental statistics
Market cap₩2.23t
Earnings (TTM)₩117.97b
Revenue (TTM)₩1.27t

18.9x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A008930 income statement (TTM)
Revenue₩1.27t
Cost of Revenue₩986.45b
Gross Profit₩284.08b
Other Expenses₩166.11b
Earnings₩117.97b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.74k
Gross Margin22.36%
Net Profit Margin9.29%
Debt/Equity Ratio24.4%

How did A008930 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

17%

Payout Ratio